Alacrita, a transatlantic management consulting firm providing expertise-based services to the pharmaceutical, biotechnology and life science sectors, was founded in 2009 by Rob Johnson and Anthony Walker. They previously worked together for over 10 years as Head of Business Development and CEO at Onyvax, a biotech company developing cancer vaccines. Before co-founding Onyvax, Anthony had been a management consultant at Arthur D. Little (where he re-launched the UK pharma consulting practice) and The Wilkerson Group in London where he focused mainly on its biotech consulting practice.
We believe that seasoned industry expertise is essential to deliver value to a sophisticated life science client – inexperienced juniors who “borrow your watch to tell you the time” are conspicuously absent from Alacrita. We hand-pick genuine experts to form tailored project teams, and work with them to define and address the challenges our clients are facing.